Meletios A Dimopoulos
Overview
Explore the profile of Meletios A Dimopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
672
Citations
23234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bakouros P, Archavli A, Kostopoulos I, Terpos E, Kastritis E, Dimopoulos M, et al.
Methods Mol Biol
. 2025 Mar;
2906:57-71.
PMID: 40082350
Cellular senescence, a stable cell cycle arrest induced by various stressors or DNA damage, plays a critical role in various aspects of human physiology, including embryonic development, wound healing, and...
2.
Sklavenitis-Pistofidis R, Konishi Y, Heilpern-Mallory D, Wu T, Tsakmaklis N, Aranha M, et al.
Nat Commun
. 2025 Feb;
16(1):1480.
PMID: 39929803
Waldenstrom's Macroglobulinemia (WM) is an IgM-secreting bone marrow (BM) lymphoma that is preceded by an asymptomatic state (AWM). To dissect tumor-intrinsic and immune mechanisms of progression, we perform single-cell RNA-sequencing...
3.
Fotiou D, Badelita S, Katodritou E, Beksac M, Bila J, Spanoudakis E, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Jan;
PMID: 39890518
Background: Multiple myeloma (MM) is predominantly a disease of the elderly, but approximately 10% of patients are younger than 50 years at diagnosis. METHODS: This study aimed to investigate the...
4.
Terpos E, Ntanasis-Stathopoulos I, Malandrakis P, Fotiou D, Migkou M, Eleutherakis-Papaiakovou E, et al.
EJHaem
. 2025 Jan;
6(1):e889.
PMID: 39866929
Background: Serum B-cell maturation antigen (sBCMA) levels have emerged as a potential biomarker for disease monitoring in multiple myeloma (MM) with prognostic value. Methods: Herein, we evaluated the sBCMA levels...
5.
Tsoukalas K, Ntanasis-Stathopoulos I, Andrikopoulou A, Tzartos J, Dimopoulos M, Gavriatopoulou M
J Clin Med
. 2025 Jan;
14(2.
PMID: 39860369
Paraneoplastic cerebellar degeneration (PCD) is an inflammatory autoimmune process caused by onconeural antibodies directed against cerebellar Purkinje cells. In most cases, prognosis is poor as disease progression leads to pancerebellar...
6.
Richardson P, Perrot A, San-Miguel J, Beksac M, Spicka I, Leleu X, et al.
Future Oncol
. 2025 Jan;
21(6):653-663.
PMID: 39851267
No abstract available.
7.
Ntanasis-Stathopoulos I, Filippatos C, Ntanasis-Stathopoulos A, Malandrakis P, Kastritis E, Tsitsilonis O, et al.
Am J Hematol
. 2025 Jan;
100(3):427-438.
PMID: 39784302
This meta-analysis examined the association between minimal residual disease (MRD) negativity and survival outcomes in 15 304 patients with multiple myeloma (MM) enrolled in randomized controlled trials published until June...
8.
Rizou A, Nasi G, Apostolakou A, Dimopoulos M, Kastritis E, Iconomidou V
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770578
At present, the complexity that governs the associations between different biological entities is understood better than ever before, owing to high-throughput techniques and systems biology. Networks of interactions are necessary...
9.
Dimopoulos M, Voorhees P, Schjesvold F, Cohen Y, Hungria V, Sandhu I, et al.
N Engl J Med
. 2024 Dec;
PMID: 39652675
Background: Daratumumab, an anti-CD38 monoclonal antibody, has been approved for the treatment of multiple myeloma. Data are needed regarding the use of daratumumab for high-risk smoldering multiple myeloma, a precursor...
10.
Drakoulidou S, Ntanasis-Stathopoulos I, Kyritsi A, Koutoulidis V, Malandrakis P, Kanellias N, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518598
Monoclonal gammopathies, such as Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM), are conditions marked by the overproduction of specific monoclonal proteins. Patients with these conditions are...